rho GTPase Activating Protein 25 (ARHGAP25) (Middle Region) Peptide
-
- Target See all ARHGAP25 products
- ARHGAP25 (rho GTPase Activating Protein 25 (ARHGAP25))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ARHGAP25 antibody (Catalog #: ARP58423_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ARHGAP25 (rho GTPase Activating Protein 25 (ARHGAP25))
- Synonyms
- arhgap24 Peptide, DKFZp468H165 Peptide, KAIA0053 Peptide, A130039I20Rik Peptide, RGD1562105 Peptide, Rho GTPase activating protein 25 Peptide, ARHGAP25 Peptide, arhgap25 Peptide, Arhgap25 Peptide
- Background
-
ARHGAPs, such as ARHGAP25, are negative regulators of Rho GTPases, which are implicated in actin remodeling, cell polarity, and cell migration.ARHGAPs, such as ARHGAP25, encode negative regulators of Rho GTPases (see ARHA, MIM 165390), which are implicated in actin remodeling, cell polarity, and cell migration (Katoh and Katoh, 2004 [PubMed 15254788]).[supplied by OMIM].
Alias Symbols: KAIA0053
Protein Size: 638 - Molecular Weight
- 70 kDa
- Gene ID
- 9938
- NCBI Accession
- NM_014882, NP_055697
- UniProt
- P42331
-